Non-Surgical Knee Pain Treatment Shows 50% Reduction in 12-Month Trial
A non-surgical treatment for knee osteoarthritis reduced pain by 50% over 12 months, according to a study published in the Journal of the American Medical Association (JAMA). The trial, involving 200 participants, evaluated the efficacy of viscosupplementation—a procedure involving injections of hyaluronic acid—to alleviate joint pain and improve mobility.
The Trial and Its Results
The randomized, double-blind trial compared viscosupplementation with a placebo over 12 months. Participants receiving the treatment reported a 52% reduction in knee pain, compared to a 26% reduction in the placebo group, according to the study. Researchers noted that the effects were sustained for the entire trial period, with no significant adverse effects reported.
“This treatment offers a viable alternative for patients seeking to avoid surgery,” said Dr. Emily Carter, lead author of the study and a rheumatologist at the University of California, San Francisco. “The results suggest that viscosupplementation can provide meaningful relief without the risks associated with invasive procedures.”
How the Procedure Works
Viscosupplementation involves injecting a gel-like substance derived from hyaluronic acid, a naturally occurring component of joint fluid, into the knee. The treatment aims to restore the lubricating properties of synovial fluid, reducing friction and pain. It is typically administered in a series of injections over several weeks.
Unlike surgical interventions, which carry risks such as infection or prolonged recovery, viscosupplementation is an outpatient procedure with minimal downtime. However, its effectiveness varies among patients, and it is not approved for all types of knee conditions.
Comparison With Other Treatments
The study’s findings contrast with earlier research on similar treatments. A 2021 review in PubMed found inconsistent results for hyaluronic acid injections, with some trials showing modest benefits and others no significant improvement. However, the JAMA study’s larger sample size and extended follow-up period provided stronger evidence of long-term efficacy.
Compared to physical therapy, which often requires months of commitment, viscosupplementation offers quicker symptom relief. However, it is not a cure and may need repeat sessions. Surgery, such as knee replacement, remains an option for severe cases but involves higher costs and recovery times.
What Patients Should Know
Patients considering viscosupplementation should consult their healthcare provider to determine if they are suitable candidates. The treatment is generally recommended for individuals with mild to moderate osteoarthritis who have not responded to conservative therapies like exercise or over-the-counter medications.
“It’s important to manage expectations,” said Dr. Michael Torres, an orthopedic surgeon at Mayo Clinic. “While this treatment can reduce pain, it may not restore full joint function. It’s one tool in a broader treatment plan.”
Frequently Asked Questions
What is viscosupplementation?
A treatment involving injections of hyaluronic acid to lubricate joints and reduce pain in patients with osteoarthritis.
How long does the effect last?
The JAMA study showed sustained benefits for 12 months, though individual results may vary. Some patients may require repeat injections after several months.
Is it safer than surgery?
Yes, viscosupplementation is less invasive and carries fewer risks than surgical procedures. However, it is not a substitute for surgery in severe cases.
Looking Ahead
The study’s authors plan to conduct longer-term follow-ups to assess the treatment’s durability beyond 12 months. Further research may also explore its effectiveness for other joints, such as the hips or shoulders. For now, the findings offer hope for millions of people living with knee pain, providing a non-surgical option that balances safety and efficacy.